P

ProteoMediX AG

11 employees

ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2010

Funding rounds raised

Total raised

$5.3M

from 9 investors over 9 rounds

P

ProteoMediX AG raised $3.2M on September 21, 2021

Investors: 诺辉健康 New Horizon Health Limited

P

ProteoMediX AG raised $5.3M on August 27, 2018

Investors: Zürcher Kantonalbank

P

ProteoMediX AG raised $5.2M on August 16, 2016

Investors: Altos Ventures and Zürcher Kantonalbank

P

ProteoMediX AG raised $3.6M on April 9, 2014

Investors: Zürcher Kantonalbank

P

ProteoMediX AG raised $2.7M on January 12, 2012

Investors: Zürcher Kantonalbank

P

ProteoMediX AG raised $93K on March 3, 2010

Investors: Venture Kick

P

ProteoMediX AG raised $19K on September 30, 2009

Investors: Venture Kick

P

ProteoMediX AG raised $10K on June 23, 2009

Investors: Venture Kick

FAQ